ACTAVIA LIFE SCIENCES, INC. Other Research and Development Expense
ACTAVIA LIFE SCIENCES, INC. reported Other Research and Development Expense of $113.00 thousand for the 12-month period ending 2023-09-30, per its 10-K filed 2024-01-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherResearchAndDevelopmentExpense · last filed 2024-01-05
- ACTAVIA LIFE SCIENCES, INC. other research and development expense for fiscal 2023 was $113.00K, a 15.31% increase from fiscal 2022.
- ACTAVIA LIFE SCIENCES, INC. other research and development expense for fiscal 2022 was $98.00K, a 52.88% decline from fiscal 2021.
- ACTAVIA LIFE SCIENCES, INC. other research and development expense for fiscal 2021 was $208.00K, a 26.76% decline from fiscal 2020.
- ACTAVIA LIFE SCIENCES, INC. other research and development expense for fiscal 2020 was $284.00K, a 36.54% increase from fiscal 2019.
| Period end | Other Research and Development Expense 12 month | Other Research and Development Expense 12 month as first filed |
|---|---|---|
| 2023-09-30 | $113.00K 10-K · filed 2024-01-05 | |
| 2022-09-30 | $98.00K 10-K · filed 2023-02-09 | |
| 2021-09-30 | $208.00K 10-K · filed 2023-02-09 | |
| 2020-09-30 | $284.00K 10-K/A · filed 2022-06-10 | $208.00K 10-K · filed 2021-01-15 |
| 2019-09-30 | $208.00K 10-K · filed 2021-01-15 | |
| 2018-09-30 | $193.00K 10-K · filed 2020-01-13 |